Genetic testing analyzes your DNA to look for changes linked to inherited conditions, disease risk, or carrier status. The process involves collecting a sample (usually blood or saliva), sending it to a certified lab where technicians read your genetic code using specialized equipment, and then receiving results classified on a scale from harmless to disease-causing. The whole process typically takes a few weeks to several months depending on the complexity of the test.
How Your DNA Sample Is Collected
Most genetic tests start with one of three sample types: blood, saliva, or a cheek swab. Blood draws are the most common method in clinical settings. A standard adult sample requires only 3 to 4 milliliters, roughly one small tube. For newborns or children, labs can work with as little as 2 milliliters. If you’ve had a blood transfusion recently, labs typically ask you to wait at least two weeks (or four weeks after a whole blood transfusion) before collecting a sample, since donor blood can contaminate results. Chemotherapy within the last 120 days can also affect DNA quality.
Saliva kits are increasingly popular, especially for at-home and direct-to-consumer testing. You spit into a small collection tube up to a marked line, then close the lid, which automatically releases a preservative solution into the sample. Pediatric kits use a slightly different container designed for assisted collection. Cheek (buccal) swabs work similarly but aren’t suitable for everyone. If you’ve had a bone marrow or stem cell transplant from a donor, a cheek swab may contain the donor’s DNA rather than your own, so an alternative sample type is required.
For prenatal genetic testing, samples come from different sources. Amniocentesis draws a small amount of fluid surrounding the fetus, while chorionic villus sampling takes a tiny piece of placental tissue. Cord blood can also be tested, though labs run a separate analysis to confirm the sample isn’t contaminated with maternal cells.
What Happens in the Lab
Once your sample arrives, lab technicians extract DNA from your cells and analyze it using one of several technologies. Which one depends on what your doctor is looking for.
Targeted sequencing examines one gene or a small panel of genes associated with a specific condition. This is common for hereditary cancer syndromes, cystic fibrosis, or sickle cell disease. Labs sometimes use an older method called Sanger sequencing to confirm results from other technologies, since it remains the gold standard for verifying individual genetic changes.
Next-generation sequencing (NGS) is the workhorse of modern genetic testing. It reads millions of short DNA fragments (100 to 300 base pairs each) simultaneously, then software stitches those fragments together into a complete picture. This approach is fast, relatively affordable, and powers everything from carrier screening panels to whole exome sequencing (which covers all 20,000-plus protein-coding genes). Newer long-read sequencing technologies can read much larger stretches of DNA, up to a million base pairs at once, making them better at detecting structural changes like large deletions or rearrangements that short-read methods can miss.
Chromosomal microarray takes a different approach entirely. Rather than reading DNA letter by letter, it scans the genome for missing or extra chunks of chromosomal material. This is often the first test ordered for children with developmental delays or intellectual disabilities.
How Results Are Classified
Genetic test results aren’t simply positive or negative. Labs classify each genetic change they find into one of five categories: pathogenic (disease-causing), likely pathogenic, variant of uncertain significance (VUS), likely benign, or benign. This five-tier system, developed by the American College of Medical Genetics, standardizes how labs communicate findings.
A pathogenic or likely pathogenic result means the lab found a change strongly associated with disease. A benign or likely benign result means the change is harmless. The trickiest category is the variant of uncertain significance. This means the lab found something unusual in your DNA but doesn’t yet have enough evidence to say whether it matters. VUS results are common, and they can sometimes be reclassified over time as researchers learn more. Your doctor or genetic counselor can help you understand what a VUS means for your specific situation.
How Long Results Take
Turnaround time varies widely. If you’re being tested for a single, well-known genetic change, results can come back in a few weeks. But if the lab needs to sequence an entire gene and doesn’t find anything, they may move on to additional genes, stretching the process to several months. Whole exome or whole genome sequencing generally takes longer than targeted panels because of the sheer volume of data involved. Rapid turnaround options exist for urgent clinical situations, like critically ill newborns, where results can sometimes be delivered in days.
What Genetic Counseling Covers
Genetic testing typically involves counseling sessions both before and after the test. In the pre-test session, a genetic counselor reviews your personal and family medical history, explains what conditions the test screens for, and walks through the potential outcomes, including the possibility of uncertain results. This session also covers the risks, benefits, and limitations of testing, and gives you a chance to clarify your own values about what you’d want to do with the information.
After results come back, a post-test session helps you interpret what the findings mean in context. If a pathogenic variant is found, the counselor discusses implications for your health, potential next steps, and whether family members should consider testing. If results are uncertain, they can explain what follow-up might look like.
Clinical Testing vs. Consumer Kits
There’s a significant difference between a test ordered by your doctor and one you buy online. Clinical genetic tests are more comprehensive. They typically examine entire genes for sequence variations, deletions, and duplications, and the results are considered diagnostic. These tests are performed in labs certified under the Clinical Laboratory Improvement Amendments (CLIA), which mandate written quality systems covering every phase of testing from sample handling to reporting.
Direct-to-consumer kits, like those from popular ancestry and health companies, test a broader but shallower slice of your genome. They look at limited, pre-selected variants or genome-wide associations rather than fully sequencing genes. Their results are not considered diagnostic, and they can be less reliable for drawing medical conclusions. A consumer test might tell you that you carry one of three common variants linked to a condition, while a clinical test would scan the entire relevant gene for any of hundreds of possible changes. If a consumer test flags something concerning, the standard recommendation is to confirm it through clinical testing before making any health decisions.
Accuracy and Limitations
Clinical genetic tests are highly accurate for the specific changes they’re designed to detect, but no test is perfect. False positives and false negatives do occur, particularly in prenatal screening. Non-invasive prenatal testing (NIPT), which analyzes fragments of fetal DNA circulating in the mother’s blood, can produce false positives due to confined placental mosaicism (where the placenta has a chromosomal abnormality the fetus doesn’t share), a vanishing twin, or copy number variations in the mother’s own genome. About 13% of false-positive cases in one study involved a vanishing twin detected on ultrasound. False negatives can result from low fetal DNA concentration in the mother’s blood, defined as less than 4% of total circulating DNA.
Beyond prenatal testing, a key limitation across all genetic tests is that a negative result doesn’t guarantee you won’t develop a condition. Many diseases involve genes or mechanisms that current tests don’t cover. And a positive result for a risk-associated variant doesn’t mean you’ll definitely get sick. Penetrance, the likelihood that a genetic change actually causes disease, varies widely across conditions and even across individuals within the same family.
What Genetic Testing Costs
Costs have dropped dramatically over the past decade. Most patients undergoing clinical genetic testing for cancer risk pay between $0 and $250 out of pocket. Many labs offer a flat self-pay rate of around $250 regardless of insurance status. Insurance coverage depends on whether you meet specific criteria, usually related to your personal or family history of disease. Medicare, for example, covers genetic testing for people with certain cancer histories. A genetic counselor can often help determine whether your insurance is likely to cover a particular test before you commit to it.